SEC Form 4 · accession 0001209191-18-046593
Endo International plc · ENDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Antonio R Pera
Officer — President, Par Pharmaceutical
Period of report
Aug 10, 2018
Accepted (ET)
Aug 14, 2018 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001593034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | Aug 10, 2018 | F | 5,585 | $15.82 | D | 34,968 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Thirty-three and one-third percent (33 1/3%) of Mr. Pera's August 10, 2017 grant of restricted stock units (RSUs) vested on August 10, 2018.
- F2These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs.
- F3Represents the vesting price which is the average of the high and low share price on August 10, 2018.